Local suture ligation‑assisted percutaneous sclerotherapy for Kasabach‑Merritt phenomenon‑associated kaposiform haemangioendothelioma

Li,Xiao; Wen,Ming‑Zhe; Su,Li‑Xin; Yang,Xi‑Tao; Han,Yi‑Feng; Fan,Xin‑Dong

doi:10.3892/ol.2018.9661

Local suture ligation‑assisted percutaneous sclerotherapy for Kasabach‑Merritt phenomenon‑associated kaposiform haemangioendothelioma

Authors:
- Xiao Li
- Ming‑Zhe Wen
- Li‑Xin Su
- Xi‑Tao Yang
- Yi‑Feng Han
- Xin‑Dong Fan
View Affiliations

Affiliations: Department of Interventional Therapy, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Stomatology and Shanghai Research Institute of Stomatology, Shanghai 200011, P.R. China
Published online on: November 2, 2018 https://doi.org/10.3892/ol.2018.9661
Pages: 981-989
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Kaposiform haemangioendotheliomas (KHEs) complicated by the Kasabach‑Merritt phenomenon (KMP) are rare and severe neoplastic lesions often associated with locally aggressive disease, consumption coagulopathy and high mortality rates. Current regimens have yet to achieve a satisfactory therapeutic effect. Thus, an effective and minimally invasive approach for treating complex KHE/KMP cases is necessary for clinical management. The present case series describes patients with KHE/KMP who underwent local suture ligation‑assisted percutaneous sclerotherapy to minimise surgical trauma and ensure effective treatment. Between September 2015 and September 2017, 3 consecutive patients with KHE/KMP underwent staged local suture ligation‑assisted percutaneous sclerotherapy. Of these patients, 2 presented with medical histories of corticosteroid treatment with unsatisfactory outcomes. The patients underwent a stepwise synthetic serial therapy programme consisting of percutaneous sclerotherapy and adjunctive pharmacotherapy accompanied by a suture ligation procedure. Clinical, radiological, pathological and laboratory data were analysed to evaluate the outcomes of the therapy. All patients were successfully managed with the proposed procedure. Significant relief of clinical symptoms and improvements in haematological indicators were achieved. No recurrence or complications were observed during regular follow‑up (4, 19 and 28 months). In conclusion, local suture ligation‑assisted percutaneous sclerotherapy was demonstrated to be a safe and effective treatment for KHE/KMP, being minimally invasive, involving simple manipulation and providing a clear treatment benefit in certain cases. Further studies involving larger sample sizes are required to thoroughly evaluate the procedure, which can potentially be used as a novel therapeutic option for KHE/KMP treatment.

View Figures

View References

1	Zukerberg LR, Nickoloff BJ and Weiss SW: Kaposiform hemangioendothelioma of infancy and childhood. An aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol. 17:321–328. 1993. View Article : Google Scholar : PubMed/NCBI
2	Croteau SE, Liang MG, Kozakewich HP, Alomari AI, Fishman SJ, Mulliken JB and Trenor CC: Kaposiform hemangioendothelioma: Atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals. J Pediatr. 162:142–147. 2013. View Article : Google Scholar : PubMed/NCBI
3	Kasabach HH and Merritt KK: Capillary hemangioma with extensive purpura. Am J Dis Child. 59:1063–1070. 1940. View Article : Google Scholar
4	Garcia-Monaco R, Giachetti A, Peralta O, Napoli N, Lobos P, Gioseffi L and Mariani G: Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: Successful treatment with embolization and vincristine in two newborns. J Vasc Interv Radiol. 23:417–422. 2012. View Article : Google Scholar : PubMed/NCBI
5	Mahajan P, Margolin J and Iacobas I: Kasabach-Merritt phenomenon: Classic presentation and management options. Clin Med Insights Blood Disord. 10:1179545X176998492017. View Article : Google Scholar : PubMed/NCBI
6	Chiu YE, Drolet BA, Blei F, Carcao M, Fangusaro J, Kelly ME, Krol A, Lofgren S, Mancini AJ, Metry DW, et al: Variable response to propranolol treatment of Kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon. Pediatr Blood Cancer. 59:934–938. 2012. View Article : Google Scholar : PubMed/NCBI
7	Jiang RS and Hu R: Successful treatment of Kasabach-Merritt syndrome arising from Kaposiform hemangioendothelioma by systemic corticosteroid therapy and surgery. Int J Clin Oncol. 17:512–516. 2012. View Article : Google Scholar : PubMed/NCBI
8	Beaubien ER, Ball NJ and Storwick GS: Kaposiform hemangioendothelioma: A locally aggressive vascular tumor. J Am Acad Dermatol. 38:799–802. 1998. View Article : Google Scholar : PubMed/NCBI
9	Liu X, Li J, Qu X, Yan W, Zhang L, Zhang S, Yang C and Zheng J: Clinical outcomes for systemic corticosteroids versus vincristine in treating Kaposiform hemangioendothelioma and tufted angioma. Medicine. 95:e34312016. View Article : Google Scholar : PubMed/NCBI
10	Lyons LL, North PE, Mac-Moune Lai F, Stoler MH, Folpe AL and Weiss SW: Kaposiform hemangioendothelioma: A study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol. 28:559–568. 2004. View Article : Google Scholar : PubMed/NCBI
11	Vivas-Colmenares GV, Ramirez-Villar GL, Bernabeu-Wittel J, Matute de Cardenas JA and Fernandez-Pineda I: The importance of early diagnosis and treatment of Kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon. Dermatol Pract Concept. 5:91–93. 2015. View Article : Google Scholar : PubMed/NCBI
12	van de Velde ME, Kaspers GL, Abbink FCH, Wilhelm AJ, Ket JCF and van den Berg MH: Vincristine-induced peripheral neuropathy in children with cancer: A systematic review. Crit Rev Oncol Hematol. 114:114–130. 2017. View Article : Google Scholar : PubMed/NCBI
13	Mota JM, Scaranti M, Fonseca LG, Tolói DA, de Camargo VP, Munhoz RR, Feher O and Hoff PM: Response to paclitaxel in an adult patient with advanced Kaposiform hemangioendothelioma. Case Rep Oncol. 9:481–487. 2016. View Article : Google Scholar : PubMed/NCBI
14	Alaqeel AM, Alfurayh NA, Alhedyani AA and Alajlan SM: Sirolimus for treatment of Kaposiform hemangioendothelioma associated with Kasabach-Merritt phenomenon. JAAD Case Rep. 2:457–461. 2016. View Article : Google Scholar : PubMed/NCBI
15	Ji Y, Chen S, Xiang B, Li K, Xu Z, Yao W, Lu G, Liu X, Xia C, Wang Q, et al: Sirolimus for the treatment of progressive Kaposiform hemangioendothelioma: A multicenter retrospective study. Int J Cancer. 141:848–855. 2017. View Article : Google Scholar : PubMed/NCBI
16	Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Jüni P, Sianos G, Hellige G, et al: Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study. Lancet. 369:667–678. 2007. View Article : Google Scholar : PubMed/NCBI
17	Reichel A, Hamm H, Wiegering V, Wiewrodt B, Neubauer H, Ernestus K and Winkler B: Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: Successful treatment with sirolimus. J Dtsch Dermatol Ges. 15:329–331. 2017. View Article : Google Scholar
18	Triana PJ, Dore M, Nuñez VC, Jimenez JG, Miguel MF, Díaz MG, Ricardo JN, Andres A, Santamaria ML and Lopez-Gutierrez JC: Pancreatic Kaposiform hemangioendothelioma not responding to sirolimus. Eur J Pediatr Surg Rep. 5:e32–e35. 2017. View Article : Google Scholar
19	Azma R, Alavi S, Khoddami M, Arzanian MT, Nourmohammad A and Esteghamati S: Multifocal kaposiform hemangioendothelioma of soft tissue with bilateral pulmonary involvement in an adolescent. Korean J Pediatr. 57:500–504. 2014. View Article : Google Scholar : PubMed/NCBI
20	Guo X, Gong Y and Dong C: Surgical treatment of a huge kaposiform hemangioendothelioma in the chest wall: A case study. SAGE Open Med Case Rep. 4:10.1177/2050313X16684742. 2016.PubMed/NCBI
21	Zahir ST, Benrazavi SS and Binesh F: Kaposiform hemangioendothelioma: Report of a case unresponsive to usual medical treatments. J Res Med Sci. 14:389–392. 2009.PubMed/NCBI
22	Leung M, Chao NS, Tang PM, Liu K and Chung KL: Pancreatic kaposiform hemangioendothelioma presenting with duodenal obstruction and kasabach-merritt phenomenon: A neonate cured by Whipple operation. Eur J Pediatr Surg Rep. 2:7–9. 2014. View Article : Google Scholar
23	Vashi P, Abboud E, Bier-Laning C and Gupta D: Adult-onset kaposiform hemangioendothelioma of the tongue: Case report and review of the literature. Curr Oncol. 23:e517–e520. 2016. View Article : Google Scholar : PubMed/NCBI
24	Vetter-Kauczok CS, Ströbel P, Bröcker EB and Becker JC: Kaposiform hemangioendothelioma with distant lymphangiomatosis without an association to Kasabach-Merritt-Syndrome in a female adult! Vasc Health Risk Manag. 4:263–266. 2008. View Article : Google Scholar : PubMed/NCBI
25	Kurian JJ, Kishore R, John TJ and Parmer H: A rare case of kaposiform hemangioendothelioma presenting as intussusception in a 4-month-old child without Kasabach-Merrit syndrome: A case report. J Indian Assoc Pediatr Surg. 19:233–235. 2014. View Article : Google Scholar : PubMed/NCBI
26	Dong A, Zhang L, Wang Y, He T and Zuo C: Abdominal kaposiform hemangioendothelioma associated with lymphangiomatosis involving mesentery and ileum: A case report of MRI, CT, and 18F-FDG PET/CT findings. Medicine (Baltimore). 95:e28062016. View Article : Google Scholar : PubMed/NCBI
27	Cinotti E and Rongioletti F: Kaposiform hemangioendothelioma. In: Rare malignant skin tumors. Rongioletti F, Margaritescu I and Smoller BR: Springer; New York, NY: pp. 161–164. 2015
28	Sarkar M, Mulliken JB, Kozakewich HP, Robertson RL and Burrows PE: Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg. 100:1377–1386. 1997. View Article : Google Scholar : PubMed/NCBI
29	Esterly NB: Kasabach-Merritt syndrome in infants. J Am Acad Dermatol. 8:504–513. 1983. View Article : Google Scholar : PubMed/NCBI
30	O'Rafferty C, O'Regan GM, Irvine AD and Smith OP: Recent advances in the pathobiology and management of Kasabach-Merritt phenomenon. Br J Haematol. 171:38–51. 2015. View Article : Google Scholar : PubMed/NCBI
31	Putra J and Gupta A: Kaposiform haemangioendothelioma: A review with emphasis on histological differential diagnosis. Pathology. 49:356–362. 2017. View Article : Google Scholar : PubMed/NCBI
32	Le HA, Jokinen CH, Rubin BP, Mihm MC, Weiss SW, North PE and Dadras SS: Expression of prox1, lymphatic endothelial nuclear transcription factor, in Kaposiform hemangioendothelioma and tufted angioma. Am J Surg Pathol. 34:1563–1573. 2010.PubMed/NCBI
33	Szlachetka DM: Kasabach-Merritt syndrome: A case review. Neonat Netw. 17:7–15. 1998.
34	Ryan C, Price V, John P, Mahant S, Baruchel S, Brandão L, Blanchette V, Pope E and Weinstein M: Kasabach-Merritt phenomenon: A single centre experience. Eur J Haematol. 84:97–104. 2010. View Article : Google Scholar : PubMed/NCBI
35	Traivaree C, Lumkul R, Torcharus K, Krutuecho T and Sriphaisal T: Outcome of Kasabach-Merritt phenomenon: The role of vincristine as monotherapy: Report of a case. J Med Assoc Thai. 95 Suppl 5:S181–S185. 2012.PubMed/NCBI
36	Dubois J, Hershon L, Carmant L, Bélanger S, Leclerc JM and David M: Toxicity profile of interferon alfa-2b in children: A prospective evaluation. J Pediatr. 135:782–785. 1999. View Article : Google Scholar : PubMed/NCBI
37	Murgia MG, Jordan S and Kahan BD: The side effect profile of sirolimus: A phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients. Kidney Int. 49:209–216. 1996. View Article : Google Scholar : PubMed/NCBI
38	Merkel S, Mogilevskaja N, Mengel M, Haller H and Schwarz A: Side effects of sirolimus. Transplant Proc. 38:714–715. 2006. View Article : Google Scholar : PubMed/NCBI
39	Li K, Tai M, Qin Z and Ge C: Clinical observations in mesh suture treatment for infants of Kasabach-Merritt phenomenon. J Paediatr Child Health. 51:529–533. 2015. View Article : Google Scholar : PubMed/NCBI
40	Gruman A, Liang MG, Mulliken JB, Fishman SJ, Burrows PE, Kozakewich HP, Blei F and Frieden IJ: Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon. J Am Acad Dermatol. 52:616–622. 2005. View Article : Google Scholar : PubMed/NCBI
41	Liu Q, Jiang L, Wu D, Kan Y, Fu F, Zhang D, Gong Y, Wang Y, Dong C and Kong L: Clinicopathological features of Kaposiform hemangioendothelioma. Int J Clin Exp Pathol. 8:13711–13718. 2015.PubMed/NCBI
42	Egashira S, Jinnin M, Harada M, Masuguchi S, Fukushima S and Ihn H: Exome sequence analysis of Kaposiform hemangioendothelioma: Identification of putative driver mutations. An Bras Dermatol. 91:748–753. 2016. View Article : Google Scholar : PubMed/NCBI